Indefinite Delivery Contract 36E79721D0042
Award Date
8/19/21
Last Date to Order
8/18/26
Federal Agency
National Acquisition Center
Awardee
Mylan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Mylan Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods. The single-award IDC, with a ceiling value of $8,346,790.65, is for the supply of clozapine tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) over a 5-year period from March 2023 to March 2026. The contract was competitively...
The federal contract IDV award is for the supply of Amitriptyline HCL tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The single-award, indefinite delivery contract was made to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceuticals. The contract aims to provide an uninterrupted source of Amitriptyline tablets in various dosages, to be distributed through the VA's...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Mylan Pharmaceuticals Inc. to provide Carbidopa-Levodopa sustained-action (SA) tablets to the Department of Veterans Affairs (VA) National Acquisition Center. The contract has a 5-year period of performance from May 2020 to May 2025, with a ceiling value of $15,670,215.75. Under this IDC, Mylan will annually supply an estimated 50,537 bottles of 100mg Carbidopa-Levodopa SA tablets and 66,850 bottles of...
The federal contract IDV is a single-award Indefinite Delivery Contract awarded by the National Acquisition Center of the Department of Veterans Affairs (VA) to The Harvard Drug Group, L.L.C. dba Major Pharmaceuticals. The contract is for the procurement of Lurasidone Hydrochloride (HCL) Tablets in various strengths, with a base ordering period of 12/10/2024 to 12/09/2025 and four one-year option periods, for a total ceiling value of $10,056,938.10. The contract will serve the VA, Department...
The federal contract IDV award is for the procurement of Zolmitriptan Tablets for the Department of Veterans Affairs (VA), Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The VA National Acquisition Center awarded a single-award Indefinite Delivery Contract to Medstone Pharma LLC, a for-profit limited liability company, with a ceiling value of $8,942,988.48. The contract has a base year from December 30, 2024 to December 29, 2025, with four...
The federal contract IDV award is for an Indefinite Delivery Contract (IDC) with a ceiling value of $6,939,222.50, awarded on July 15, 2019 to the prime contractor Specgx LLC, doing business as Mallinckrodt Pharmaceuticals. The contract was awarded by the Defense Logistics Agency, a component of the U.S. Department of Defense, to establish a national supply source for pharmaceutical products used by the Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans...
Mylan Pharmaceuticals Inc. is providing pharmaceutical products to the Department of Veterans Affairs National Acquisition Center under a single-award Indefinite Delivery Contract. The contract has a potential value of $92.9 million and a period of performance through August 2024. Under the terms of the contract, Mylan will supply divalproex sodium tablets to meet the medication needs of veterans served by VA, DoD, Bureau of Prisons and Indian Health Service medical facilities nationwide. As the...
The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) held by Radha Pharmaceuticals Inc., a minority-owned and small disadvantaged business, to provide various strengths and bottle configurations of hydralazine tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service. The $11,999,990.25 IDC has a base year period of performance from April 8, 2021 to April 7, 2022, with four one-year option...
The federal contract IDV award is a single award Indefinite Delivery Contract between the Department of Veterans Affairs (VA) National Acquisition Center and Sandoz Inc., a global pharmaceutical company, to provide a variety of prescription medications through the VA and Department of Defense (DoD) pharmaceutical prime vendor programs. The contract has a base period of performance from May 30, 2021 to May 29, 2022 with four one-year option periods, and a ceiling value of $9,803,319.55. The...
The federal contract IDV award is for the delivery of Carvedilol Tablets to support multiple federal agencies including the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract was awarded to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a base period of one year with four one-year option periods, for...